Concepedia

Publication | Open Access

Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4)

DOIFull Paper Access

27

Citations

16

References

2023

Year

Litong Qi, Dexue Liu, Yanling Qu, Beijian Chen, Haiyan Meng, Lei Zhu, Lipeng Li, Shuqing Wang, Changyi Liu, Guanzhong Zheng,
JACC Asia

Abstract

Tafolecimab was safe and showed robust lipid-lowering efficacy in Chinese patients at high or very high cardiovascular risk with hypercholesterolemia. (A Study of IBI306 in Participants With Hypercholesterolemia; NCT04709536).

References

YearCitations

Page 1